# Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation

> **NCT02569736** · — · COMPLETED · sponsor: **Association Aquitaine de Recherche Clinique en Rhumatologie** · enrollment: 60 (actual)

## Conditions studied

- Arthritis, Rheumatoid
- Tocilizumab
- T-Lymphocytes, Helper-Inducer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02569736
- **Lead sponsor:** Association Aquitaine de Recherche Clinique en Rhumatologie
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-09
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-01-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02569736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02569736, "Characterization of the Effect of Tocilizumab in Vivo and in Vitro on T Follicular Helper Cells in Rheumatoid Arthritis Patients and Consequence on B Cells Maturation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02569736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*